BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358

  May 29, 2026

   · 

  5 min read
• Press Releases

  Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

  May 29, 2026

   · 

  3 min read
• Press Releases

  SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund

  May 29, 2026

   · 

  4 min read
• Press Releases

  FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

  May 29, 2026

   · 

  19 min read
• Press Releases

  Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

  May 29, 2026

   · 

  19 min read
• Press Releases

  Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma

  May 29, 2026

   · 

  7 min read
• Press Releases

  Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR and EHA 2026 Congresses

  May 29, 2026

   · 

  4 min read
• Press Releases

  PanTher Completes Dose Escalation Phase in Non-Metastatic Pancreatic Cancer Phase 1b Trial and Appoints Tim Clackson to the Board of Directors

  May 29, 2026

   · 

  6 min read
• Press Releases

  Defence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian

  May 29, 2026

   · 

  3 min read
• Press Releases

  Theralase(R) Releases Q1 2026 Financial Statements

  Theralase(R) Provides an Update on its Phase II Bladder Cancer Clinical Study

  May 29, 2026

   · 

  13 min read